clinical trials

Weak clinical data force Sanofi, GSK to delay COVID-19 vaccine
Weak clinical data force Sanofi, GSK to delay COVID-19 vaccine
Fierce Biotech
Sanofi
GSK
vaccines
COVID-19
clinical trials
Flag link:
Moderna doses adolescents in COVID-19 vaccine study, setting it up to target 2021-22 school year
Moderna doses adolescents in COVID-19 vaccine study, setting it up to target 2021-22 school year
Fierce Biotech
Moderna Therapeutics
adolescents
clinical trials
vaccines
COVID-19
Flag link:
NASA-partnered Pluristem crashes to Earth as it axes leading therapy
NASA-partnered Pluristem crashes to Earth as it axes leading therapy
Fierce Biotech
Pluristem
clinical trials
R&D
critical limb ischemia
Flag link:
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
AbbVie
Rinvoq
ulcerative colitis
clinical trials
Flag link:
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
Motley Fool
Sorrento Therapeutics
clinical trials
STI-1499
COVI-GUARD
COVID-19
Flag link:
Johnson & Johnson cuts size of Covid-19 vaccine study due to prevalence of disease in U.S.
Johnson & Johnson cuts size of Covid-19 vaccine study due to prevalence of disease in U.S.
Stat
JNJ
clinical trials
COVID-19
vaccines
Flag link:
AstraZeneca COVID-19 vaccine data hint at single-dose efficacy, effect on asymptomatic cases
AstraZeneca COVID-19 vaccine data hint at single-dose efficacy, effect on asymptomatic cases
Fierce Biotech
AstraZeneca
vaccines
COVID-19
AZD1222
clinical trials
Flag link:
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Flag link:
Pfizer’s Vaccine Offers Strong Protection After First Dose
Pfizer’s Vaccine Offers Strong Protection After First Dose
NY Times, NY
Pfizer
vaccines
BioNTech
COVID-19
clinical trials
Flag link:
Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial
Inovio doses first patient in phase 2 segment of Covid-19 DNA vaccine candidate trial
Pharmaceutical Business Review
Inovio
clinical trials
vaccines
INO-4800
COVID-19
Flag link:
ASH: Gilead's CAR-T med Yescarta shows promise earlier in lymphoma therapy
ASH: Gilead's CAR-T med Yescarta shows promise earlier in lymphoma therapy
Fierce Pharma
Gilead Sciences
Kite Pharma
Yescarta
diffuse large B-cell lymphoma
clinical trials
Flag link:
U.S. AstraZeneca vaccine trial will clear confusion on how well it works - U.S. scientist
U.S. AstraZeneca vaccine trial will clear confusion on how well it works - U.S. scientist
Reuters
AstraZeneca
clinical trials
vaccines
COVID-19
Flag link:
Amid a record bad year, Bellicum keeps taking its lumps as FDA slams trial hold on CAR-T hopeful
Amid a record bad year, Bellicum keeps taking its lumps as FDA slams trial hold on CAR-T hopeful
Endpoints
Bellicum
FDA
BPX-601
pancreatic cancer
clinical trials
clinical hold
Flag link:
ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits
ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits
Fierce Pharma
ASH2020
Novartis
Kymriah
follicular lymphoma
clinical trials
Flag link:
#ASH20: In a multiple myeloma showdown, Regeneron marches out new PhI data for its BCMA bispecific
#ASH20: In a multiple myeloma showdown, Regeneron marches out new PhI data for its BCMA bispecific
Endpoints
ASH2020
Regeneron
Multiple Myeloma
clinical trials
REGN5458
Flag link:
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
Endpoints
ASH2020
Eli Lilly
clinical trials
LOXO-305
Loxo Oncology
mantle cell lymphoma
non-Hodgkin lymphoma
Flag link:
Moderna's 3-month data raise hopes for COVID-19 vaccine durability
Moderna's 3-month data raise hopes for COVID-19 vaccine durability
Fierce Biotech
Moderna Therapeutics
mRNA-1273
COVID-19
clinical trials
vaccines
Flag link:
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks
Fierce Biotech
Takeda
TAK-620
clinical trials
CMV
Flag link:
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Fierce Biotech
Clover BioPharmaceuticals
clinical trials
COVID-19
vaccines
GSK
Flag link:
Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
EP Vantage
Galapagos
GLPG1205
idiopathic pulmonary fibrosis
clinical trials
Flag link:

Pages